Ascendis Pharma A/S (ASND) Form 6-K — Oct 14, 2026
Ascendis Pharma's board granted 35,890 warrants to certain employees on October 13, 2026, each exercisable for one ordinary share at US $223.21, the closing price on the grant date. The warrants vest 25% after one year with the remaining 75% vesting at 1/36 per month thereafter, subject to accelerated vesting on certain exit events. After this grant, warrants covering 1,459,173 additional shares remain available for future issuance.
Key figures
- Vesting
- 25% at 1 year, remaining 75% at 1/36 per month thereafter
- Warrants granted
- 35890
- Exercise price usd
- 223.21
- Share capital nominal dkk
- 66400738
- Total warrants issued to date
- 13701610
- Warrants exercised annulled lapsed
- 9087833
- Warrants available for future grant
- 1459173
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.